Yang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yang Chen has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Dandan Wang
State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Department of Biomedicine, School of Life Sciences and Technology, Tongji University, Shanghai, China
2 shared publicationsRuhua Deng
State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Department of Biomedicine, School of Life Sciences and Technology, Tongji University, Shanghai, China
2 shared publicationsXingbo Yang
State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Department of Biomedicine, School of Life Sciences and Technology, Tongji University, Shanghai, China
2 shared publications- Yaozu Xiang
State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Department of Biomedicine, School of Life Sciences and Technology, Tongji University, Shanghai, China.
2 shared publications Yelin Wu
Institute of Hepatobiliary and Pancreatic Surgery Department of Hepatobiliary and Pancreatic Surgery Shanghai East Hospital School of Life Sciences and Technology Tongji University Shanghai 200120 P. R. China
2 shared publications- Yue Xu
State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Department of Biomedicine, School of Life Sciences and Technology, Tongji University, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Mitochondria-derived vesicles with bioenergetic units from brown adipose tissue attenuate cardiac remodeling post-myocardial infarction
Post-myocardial infarction remodeling is a major cause of heart failure, with contributions from multiple organs. Brown adipose tissue protects against cardiovascular disease, but the mediators of brown adipose tissue-heart crosstalk and their roles in cardiac remodeling remain elusive. Here, we show that mitochondria-derived vesicles from brown adipose tissue transfer to cardiac macrophages and attenuate pathological remodeling via anti-inflammatory effects. Vesicles containing mitochondrial membranes, rather than mitochondrial matrix, mobilize from brown adipose tissue to the heart in response to stress. VPS35 translocation to mitochondria drives protein packaging into mitochondria-derived vesicles for secretion through extracellular vesicle trafficking machinery. Becn1 deficiency impairs VPS35 translocation, alters mitochondria-derived vesicle cargo, and abolishes brown adipose tissue-mediated cardioprotection. Proteomics identifies mitochondrial respiratory chain complex V as a hallmark of protective mitochondria-derived vesicles. These vesicles enhance reparative cytokine production and oxidative phosphorylation rewiring in macrophages. Purified mitochondria-derived vesicles markedly improve remodeling in male mice. Our study uncovers an interorgan transfer of bioenergetic units that contributes to tissue repair.
- 21 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMitochondria-derived vesicles with bioenergetic units from brown adipose tissue attenuate cardiac remodeling post-myocardial infarction
Post-myocardial infarction remodeling is a major cause of heart failure, with contributions from multiple organs. Brown adipose tissue protects against cardiovascular disease, but the mediators of brown adipose tissue-heart crosstalk and their roles in cardiac remodeling remain elusive. Here, we show that mitochondria-derived vesicles from brown adipose tissue transfer to cardiac macrophages and attenuate pathological remodeling via anti-inflammatory effects. Vesicles containing mitochondrial membranes, rather than mitochondrial matrix, mobilize from brown adipose tissue to the heart in response to stress. VPS35 translocation to mitochondria drives protein packaging into mitochondria-derived vesicles for secretion through extracellular vesicle trafficking machinery. Becn1 deficiency impairs VPS35 translocation, alters mitochondria-derived vesicle cargo, and abolishes brown adipose tissue-mediated cardioprotection. Proteomics identifies mitochondrial respiratory chain complex V as a hallmark of protective mitochondria-derived vesicles. These vesicles enhance reparative cytokine production and oxidative phosphorylation rewiring in macrophages. Purified mitochondria-derived vesicles markedly improve remodeling in male mice. Our study uncovers an interorgan transfer of bioenergetic units that contributes to tissue repair.
- 31 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e01819
Magnetic Force Enhances Pharmacologic Thrombolysis by Unlocking the “Knob‐Hole” Structure of Fibrin
Thrombosis is a prevalent pathology underlying cardiovascular diseases, and pharmacologic thrombolysis is widely used in clinical. However, the dense structure of the fibrin network restricts the penetration and mobility of thrombolytic drugs within the thrombus, thereby reducing their efficiency. Disrupting the integrity of the thrombus requires high energy and generates small pieces of thrombus that increase the risk of pulmonary embolism. Here, it is demonstrated that applying a magnetic force at the pN level to unlock the “knob‐hole” structure of fibrin disrupts the dense and stable mechanical state of the thrombus, consequently enhanced the efficiency of drug thrombolysis. Specifically, hollow shuttle‐shaped magnetic nanoparticles are synthesized that rotate in response to an applied rotating magnetic field, generating mechanical forces to unlock the “knob‐hole” structure. This led to filament disconnections within fibrin as well as exposed more binding sites for thrombolytic drugs. Meanwhile, the loaded thrombolytic drug is released at the thrombus site along with the rotation of magnetic nanoparticles. The results show that magnetic‐assisted drug thrombolysis is 4.75 times more efficient than free drugs in the venous thrombosis mouse model. This non‐invasive magnetic force‐enhanced pharmacologic thrombolysis provides a safe and efficient thrombolysis technology and suggests external physical energies as potent biomolecular regulation means.
- 31 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e01819
Magnetic Force Enhances Pharmacologic Thrombolysis by Unlocking the “Knob‐Hole” Structure of Fibrin
Thrombosis is a prevalent pathology underlying cardiovascular diseases, and pharmacologic thrombolysis is widely used in clinical. However, the dense structure of the fibrin network restricts the penetration and mobility of thrombolytic drugs within the thrombus, thereby reducing their efficiency. Disrupting the integrity of the thrombus requires high energy and generates small pieces of thrombus that increase the risk of pulmonary embolism. Here, it is demonstrated that applying a magnetic force at the pN level to unlock the “knob‐hole” structure of fibrin disrupts the dense and stable mechanical state of the thrombus, consequently enhanced the efficiency of drug thrombolysis. Specifically, hollow shuttle‐shaped magnetic nanoparticles are synthesized that rotate in response to an applied rotating magnetic field, generating mechanical forces to unlock the “knob‐hole” structure. This led to filament disconnections within fibrin as well as exposed more binding sites for thrombolytic drugs. Meanwhile, the loaded thrombolytic drug is released at the thrombus site along with the rotation of magnetic nanoparticles. The results show that magnetic‐assisted drug thrombolysis is 4.75 times more efficient than free drugs in the venous thrombosis mouse model. This non‐invasive magnetic force‐enhanced pharmacologic thrombolysis provides a safe and efficient thrombolysis technology and suggests external physical energies as potent biomolecular regulation means.
- Top Cited Papers
- 19 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (23) , 2223-2238
Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils
Backgrounds and Aims: Patients with periodontitis (PD) are prone to developing myocardial infarction (MI), yet the prognosis and mechanisms remain unclear. Given the presumed close association of neutrophils with both conditions, this study aims to elucidate the roles of neutrophils in mediating the interaction between PD and MI. Methods: Three prospective cohorts and PD + MI mouse model were investigated to assess the effects of PD on MI prognosis. Single-cell-RNA sequencing and genome-wide association study were employed to identify the neutrophil subtype involved. To characterize the function of SiglecF+ neutrophils, bone marrow transplantation, Edu-pulse chasing, lineage tracing, and collagen contraction assay were utilized. Adoptive neutrophil transfer, conditional Siglecf knockout and lipid nanoparticles facilitating local SiglecF+ neutrophils depletion was harnessed to explore the roles of SiglecF+ neutrophils in MI repair. Results: Persisting but not short-term PD upset MI prognosis (cardiac fibrosis and function) in human and mice. Bone marrow neutrophils of PD were intrinsically skewed toward longer-lived SiglecF+ neutrophil differentiation, a subtype that was converted by GMCSF or TGFβ in PPARγ-dependent manner. SiglecF+ neutrophils were expanded in infarcted PD heart where they deposit collagen and activate fibroblasts to instigate excessive fibrosis. SiglecF+ neutrophil depletion was efficacious for mitigating fibrosis. Conclusions: This study demonstrated that long-lasting PD-aggravated MI prognosis by expanding scar-associated SiglecF+ neutrophils into the heart and highlighted the clinical relevance of oral health examination for treating MI in a holistic fashion.
- 19 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (23) , 2223-2238
Top Cited PapersPeriodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils
Backgrounds and Aims: Patients with periodontitis (PD) are prone to developing myocardial infarction (MI), yet the prognosis and mechanisms remain unclear. Given the presumed close association of neutrophils with both conditions, this study aims to elucidate the roles of neutrophils in mediating the interaction between PD and MI. Methods: Three prospective cohorts and PD + MI mouse model were investigated to assess the effects of PD on MI prognosis. Single-cell-RNA sequencing and genome-wide association study were employed to identify the neutrophil subtype involved. To characterize the function of SiglecF+ neutrophils, bone marrow transplantation, Edu-pulse chasing, lineage tracing, and collagen contraction assay were utilized. Adoptive neutrophil transfer, conditional Siglecf knockout and lipid nanoparticles facilitating local SiglecF+ neutrophils depletion was harnessed to explore the roles of SiglecF+ neutrophils in MI repair. Results: Persisting but not short-term PD upset MI prognosis (cardiac fibrosis and function) in human and mice. Bone marrow neutrophils of PD were intrinsically skewed toward longer-lived SiglecF+ neutrophil differentiation, a subtype that was converted by GMCSF or TGFβ in PPARγ-dependent manner. SiglecF+ neutrophils were expanded in infarcted PD heart where they deposit collagen and activate fibroblasts to instigate excessive fibrosis. SiglecF+ neutrophil depletion was efficacious for mitigating fibrosis. Conclusions: This study demonstrated that long-lasting PD-aggravated MI prognosis by expanding scar-associated SiglecF+ neutrophils into the heart and highlighted the clinical relevance of oral health examination for treating MI in a holistic fashion.
- 11 June 2024
- Published by Springer Nature in Nature Nanotechnology
- Vol. 19 (9) , 1399-1408
Nutrient-delivery and metabolism reactivation therapy for melanoma
To fulfil the demands of rapid proliferation, tumour cells undergo significant metabolic alterations. Suppression of hyperactivated metabolism has been proven to counteract tumour growth. However, whether the reactivation of downregulated metabolic pathways has therapeutic effects remains unexplored. Here we report a nutrient-based metabolic reactivation strategy for effective melanoma treatment. l-Tyrosine–oleylamine nanomicelles (MTyr–OANPs) were constructed for targeted supplementation of tyrosine to reactivate melanogenesis in melanoma cells. We found that reactivation of melanogenesis using MTyr–OANPs significantly impeded the proliferation of melanoma cells, primarily through the inhibition of glycolysis. Furthermore, leveraging melanin as a natural photothermal reagent for photothermal therapy, we demonstrated the complete eradication of tumours in B16F10 melanoma-bearing mice through treatment with MTyr–OANPs and photothermal therapy. Our strategy for metabolism activation-based tumour treatment suggests specific nutrients as potent activators of metabolic pathways.
- 11 June 2024
- Published by Springer Nature in Nature Nanotechnology
- Vol. 19 (9) , 1399-1408
Nutrient-delivery and metabolism reactivation therapy for melanoma
To fulfil the demands of rapid proliferation, tumour cells undergo significant metabolic alterations. Suppression of hyperactivated metabolism has been proven to counteract tumour growth. However, whether the reactivation of downregulated metabolic pathways has therapeutic effects remains unexplored. Here we report a nutrient-based metabolic reactivation strategy for effective melanoma treatment. l-Tyrosine–oleylamine nanomicelles (MTyr–OANPs) were constructed for targeted supplementation of tyrosine to reactivate melanogenesis in melanoma cells. We found that reactivation of melanogenesis using MTyr–OANPs significantly impeded the proliferation of melanoma cells, primarily through the inhibition of glycolysis. Furthermore, leveraging melanin as a natural photothermal reagent for photothermal therapy, we demonstrated the complete eradication of tumours in B16F10 melanoma-bearing mice through treatment with MTyr–OANPs and photothermal therapy. Our strategy for metabolism activation-based tumour treatment suggests specific nutrients as potent activators of metabolic pathways.